SEEING COMPLEXITY
IN A NEW LIGHT

Where others see complexity, we see value for patients and shareholders

SEEING VALUE
FOR PATIENTS

Where others see complexity, we see healthier lives

SEEING OPPORTUNITY
FOR SHAREHOLDERS

Where others see complexity, we see potential for growth

Managing Complexity.
Improving Lives.

For more than 150 years, Mallinckrodt has been advancing the fields of science and medicine to improve the lives of people around the world.

About Us

Bold Path.
Brighter Future.

Grow your career, and become part of our legacy as we make a lasting difference in the lives of patients.

Careers

A Diverse and
Growing Pipeline.

Mallinckrodt is focused on developing innovative therapies and cutting-edge technologies for patients with severe and critical conditions and has products spanning all phases of clinical development.

Pipeline

Managing Complexity. Improving Lives.

News & Media

Mallinckrodt to Present New Retrospective Data on Effect of Acthar® Gel (Repository Corticotropin Injection) to Reduce Corticosteroid Use and Burden for Advanced Sarcoidosis at the Academy of Managed Care Pharmacy (AMCP) 2023 Annual Meeting

Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)

Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance

COVID-19 Resources

We are so grateful for all first responders, healthcare professionals and essential employees' efforts in the battle against COVID-19. We believe in listening to needs and delivering solutions and we are proud to join you in the fight. We are doing a variety of things to make a difference.

Learn More

Successful Completion of Financial Reorganization

Go to mnk.com/corporatefactsheet to learn more about Mallinckrodt and our path forward.

A Diverse and Growing Pipeline

Mallinckrodt is focused on developing innovative therapies and cutting-edge technologies for patients with severe and critical conditions and has products spanning all phases of clinical development.

View Our Pipeline

2020 Corporate Social Responsibility Report Released

Mallinckrodt releases its 2020 Corporate Social Responsibility Report highlighting our continued commitment and ongoing progress.

Inclusion & Diversity

We are strengthened by the value we derive from the varied identities, experiences, cultures and views of our employees.

Our Commitment

Our Product Pricing

Our goal is to price our products responsibly while providing the best possible healthcare for the greatest number of people.

Product Pricing

Our Products

Building on our heritage and distinctive capabilities, our world-class development and formulation expertise bring medical solutions to the marketplace.

Get Product Information

SEEING COMPLEXITY
IN A NEW LIGHT

SEEING VALUE
FOR PATIENTS